<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1993-10-01" modified="2020-12-02" version="242">
<accession>Q04206</accession>
<accession>Q6GTV1</accession>
<accession>Q6SLK1</accession>
<name>TF65_HUMAN</name>
<protein>
<recommendedName>
<fullName>Transcription factor p65</fullName>
</recommendedName>
<alternativeName>
<fullName>Nuclear factor NF-kappa-B p65 subunit</fullName>
</alternativeName>
<alternativeName>
<fullName>Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">RELA</name>
<name type="synonym">NFKB3</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Science" volume="251" first="1490" last="1493">
<title>Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B.</title>
<authorList>
<person name="Ruben S.M."/>
<person name="Dillon P.J."/>
<person name="Schreck R."/>
<person name="Henkel T."/>
<person name="Chen C.-H."/>
<person name="Maher M."/>
<person name="Baeuerle P.A."/>
<person name="Rosen C.A."/>
</authorList>
<dbReference type="PubMed" id="2006423"/>
<dbReference type="DOI" id="10.1126/science.2006423"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1993" name="Hum. Mol. Genet." volume="2" first="1895" last="1900">
<title>Genomic organization of the gene encoding the p65 subunit of NF-kappa B: multiple variants of the p65 protein may be generated by alternative splicing.</title>
<authorList>
<person name="Deloukas P."/>
<person name="van Loon A.P.G.M."/>
</authorList>
<dbReference type="PubMed" id="8281153"/>
<dbReference type="DOI" id="10.1093/hmg/2.11.1895"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1994" name="Gene" volume="138" first="265" last="266">
<title>An alternatively spliced transcript, p65 delta 2, of the gene encoding the p65 subunit of the transcription factor NF-kappa B.</title>
<authorList>
<person name="Lyle R."/>
<person name="Valleley E.M."/>
<person name="Sharpe P.T."/>
<person name="Hewitt J.E."/>
</authorList>
<dbReference type="PubMed" id="7907305"/>
<dbReference type="DOI" id="10.1016/0378-1119(94)90823-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Bone</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4)</scope>
<source>
<tissue>Colon</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2003-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 4-551</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1992" name="Mol. Cell. Biol." volume="12" first="444" last="454">
<title>Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative.</title>
<authorList>
<person name="Ruben S.M."/>
<person name="Narayanan R."/>
<person name="Klement J.F."/>
<person name="Chen C.-H."/>
<person name="Rosen C.A."/>
</authorList>
<dbReference type="PubMed" id="1732726"/>
<dbReference type="DOI" id="10.1128/mcb.12.2.444"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 214-239 (ISOFORMS 1/2 AND 3)</scope>
<scope>REGION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1992" name="EMBO J." volume="11" first="205" last="213">
<title>A novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene.</title>
<authorList>
<person name="Hansen S.K."/>
<person name="Nerlov C."/>
<person name="Zabel U."/>
<person name="Verde P."/>
<person name="Johnsen M."/>
<person name="Baeuerle P.A."/>
<person name="Blasi F."/>
</authorList>
<dbReference type="PubMed" id="1740106"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1992.tb05043.x"/>
</citation>
<scope>IDENTIFICATION IN THE NF-KAPPA-B P65-P50 COMPLEX</scope>
<scope>IDENTIFICATION IN THE NF-KAPPA-B P65-C-REL COMPLEX</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1992" name="Mol. Biol. Cell" volume="3" first="1339" last="1352">
<title>I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.</title>
<authorList>
<person name="Ganchi P.A."/>
<person name="Sun S.C."/>
<person name="Greene W.C."/>
<person name="Ballard D.W."/>
</authorList>
<dbReference type="PubMed" id="1493333"/>
<dbReference type="DOI" id="10.1091/mbc.3.12.1339"/>
</citation>
<scope>INTERACTION WITH NFKBIA</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1994" name="Oncogene" volume="9" first="1487" last="1492">
<title>Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor.</title>
<authorList>
<person name="Beg A.A."/>
<person name="Baldwin A.S. Jr."/>
</authorList>
<dbReference type="PubMed" id="8152812"/>
</citation>
<scope>IDENTIFICATION IN THE NF-KAPPA-B P65-C-REL COMPLEX</scope>
<scope>IDENTIFICATION IN THE NF-KAPPA-B P65-P52 COMPLEX</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1997" name="Cell Growth Differ." volume="8" first="335" last="342">
<title>Regulation of intercellular adhesion molecule-1 gene by tumor necrosis factor-alpha is mediated by the nuclear factor-kappaB heterodimers p65/p65 and p65/c-Rel in the absence of p50.</title>
<authorList>
<person name="Aoudjit F."/>
<person name="Brochu N."/>
<person name="Belanger B."/>
<person name="Stratowa C."/>
<person name="Hiscott J."/>
<person name="Audette M."/>
</authorList>
<dbReference type="PubMed" id="9056676"/>
</citation>
<scope>IDENTIFICATION IN THE NF-KAPPA-B P65-P65 COMPLEX</scope>
<scope>IDENTIFICATION IN THE NF-KAPPA-B P65-C-REL COMPLEX</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1997" name="Mol. Cell. Biol." volume="17" first="6184" last="6190">
<title>A new member of the IkappaB protein family, IkappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription.</title>
<authorList>
<person name="Li Z."/>
<person name="Nabel G.J."/>
</authorList>
<dbReference type="PubMed" id="9315679"/>
<dbReference type="DOI" id="10.1128/mcb.17.10.6184"/>
</citation>
<scope>INTERACTION WITH NFKBIE</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1998" name="Nature" volume="395" first="292" last="296">
<title>IKAP is a scaffold protein of the IkappaB kinase complex.</title>
<authorList>
<person name="Cohen L."/>
<person name="Henzel W.J."/>
<person name="Baeuerle P.A."/>
</authorList>
<dbReference type="PubMed" id="9751059"/>
<dbReference type="DOI" id="10.1038/26254"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH CHUK; IKBKB; NFKBIA; ELP1 AND MAP3K14</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="30353" last="30356">
<title>IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain.</title>
<authorList>
<person name="Sakurai H."/>
<person name="Chiba H."/>
<person name="Miyoshi H."/>
<person name="Sugita T."/>
<person name="Toriumi W."/>
</authorList>
<dbReference type="PubMed" id="10521409"/>
<dbReference type="DOI" id="10.1074/jbc.274.43.30353"/>
</citation>
<scope>PHOSPHORYLATION AT SER-536</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="Oncogene" volume="18" first="5177" last="5186">
<title>NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2.</title>
<authorList>
<person name="Yang J.-P."/>
<person name="Hori M."/>
<person name="Takahashi N."/>
<person name="Kawabe T."/>
<person name="Kato H."/>
<person name="Okamoto T."/>
</authorList>
<dbReference type="PubMed" id="10498867"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202904"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH TP53BP2</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2000" name="FASEB J." volume="14" first="1471" last="1484">
<title>Yersinia enterocolitica invasin protein triggers IL-8 production in epithelial cells via activation of Rel p65-p65 homodimers.</title>
<authorList>
<person name="Schulte R."/>
<person name="Grassl G.A."/>
<person name="Preger S."/>
<person name="Fessele S."/>
<person name="Jacobi C.A."/>
<person name="Schaller M."/>
<person name="Nelson P.J."/>
<person name="Autenrieth I.B."/>
</authorList>
<dbReference type="PubMed" id="10928981"/>
<dbReference type="DOI" id="10.1096/fj.99-0847com"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN THE NF-KAPPA-B P65-P65 COMPLEX</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="4383" last="4390">
<title>Inhibition of nuclear factor-kappaB-mediated transcription by association with the amino-terminal enhancer of split, a Groucho-related protein lacking WD40 repeats.</title>
<authorList>
<person name="Tetsuka T."/>
<person name="Uranishi H."/>
<person name="Imai H."/>
<person name="Ono T."/>
<person name="Sonta S."/>
<person name="Takahashi N."/>
<person name="Asamitsu K."/>
<person name="Okamoto T."/>
</authorList>
<dbReference type="PubMed" id="10660609"/>
<dbReference type="DOI" id="10.1074/jbc.275.6.4383"/>
</citation>
<scope>INTERACTION WITH TLE5 AND TLE1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="32592" last="32597">
<title>Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II.</title>
<authorList>
<person name="Wang D."/>
<person name="Westerheide S.D."/>
<person name="Hanson J.L."/>
<person name="Baldwin A.S. Jr."/>
</authorList>
<dbReference type="PubMed" id="10938077"/>
<dbReference type="DOI" id="10.1074/jbc.m001358200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-529</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2001" name="Oncogene" volume="20" first="4917" last="4925">
<title>The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation.</title>
<authorList>
<person name="Heppner C."/>
<person name="Bilimoria K.Y."/>
<person name="Agarwal S.K."/>
<person name="Kester M."/>
<person name="Whitty L.J."/>
<person name="Guru S.C."/>
<person name="Chandrasekharappa S.C."/>
<person name="Collins F.S."/>
<person name="Spiegel A.M."/>
<person name="Marx S.J."/>
<person name="Burns A.L."/>
</authorList>
<dbReference type="PubMed" id="11526476"/>
<dbReference type="DOI" id="10.1038/sj.onc.1204529"/>
</citation>
<scope>INTERACTION WITH MEN1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2001" name="Science" volume="293" first="1653" last="1657">
<title>Duration of nuclear NF-kappaB action regulated by reversible acetylation.</title>
<authorList>
<person name="Chen L.F."/>
<person name="Fischle W."/>
<person name="Verdin E."/>
<person name="Greene W.C."/>
</authorList>
<dbReference type="PubMed" id="11533489"/>
<dbReference type="DOI" id="10.1126/science.1062374"/>
</citation>
<scope>ACETYLATION</scope>
<scope>INTERACTION WITH HDAC3</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2002" name="Cancer Cell" volume="2" first="335" last="346">
<title>A novel protein overexpressed in hepatoma accelerates export of NF-kappa B from the nucleus and inhibits p53-dependent apoptosis.</title>
<authorList>
<person name="Higashitsuji H."/>
<person name="Higashitsuji H."/>
<person name="Nagao T."/>
<person name="Nonoguchi K."/>
<person name="Fujii S."/>
<person name="Itoh K."/>
<person name="Fujita J."/>
</authorList>
<dbReference type="PubMed" id="12398897"/>
<dbReference type="DOI" id="10.1016/s1535-6108(02)00152-6"/>
</citation>
<scope>INTERACTION WITH ETHE1</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="6539" last="6548">
<title>Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB.</title>
<authorList>
<person name="Chen L.F."/>
<person name="Mu Y."/>
<person name="Greene W.C."/>
</authorList>
<dbReference type="PubMed" id="12456660"/>
<dbReference type="DOI" id="10.1093/emboj/cdf660"/>
</citation>
<scope>ACETYLATION AT LYS-218; LYS-221 AND LYS-310</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2002" name="Mol. Cell" volume="9" first="625" last="636">
<title>The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1.</title>
<authorList>
<person name="Zhong H."/>
<person name="May M.J."/>
<person name="Jimi E."/>
<person name="Ghosh S."/>
</authorList>
<dbReference type="PubMed" id="11931769"/>
<dbReference type="DOI" id="10.1016/s1097-2765(02)00477-x"/>
</citation>
<scope>INTERACTION WITH CBP AND HDAC1</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="EMBO J." volume="22" first="1313" last="1324">
<title>Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1).</title>
<authorList>
<person name="Vermeulen L."/>
<person name="De Wilde G."/>
<person name="Van Damme P."/>
<person name="Vanden Berghe W."/>
<person name="Haegeman G."/>
</authorList>
<dbReference type="PubMed" id="12628924"/>
<dbReference type="DOI" id="10.1093/emboj/cdg139"/>
</citation>
<scope>INTERACTION WITH RPS6KA5</scope>
<scope>MUTAGENESIS OF SER-276</scope>
<scope>PHOSPHORYLATION AT SER-276</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="2758" last="2766">
<title>Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65.</title>
<authorList>
<person name="Kiernan R."/>
<person name="Bres V."/>
<person name="Ng R.W."/>
<person name="Coudart M.-P."/>
<person name="El Messaoudi S."/>
<person name="Sardet C."/>
<person name="Jin D.-Y."/>
<person name="Emiliani S."/>
<person name="Benkirane M."/>
</authorList>
<dbReference type="PubMed" id="12419806"/>
<dbReference type="DOI" id="10.1074/jbc.m209572200"/>
</citation>
<scope>ACETYLATION AT LYS-122 AND LYS-123</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="26879" last="26887">
<title>RING finger protein AO7 supports NF-kappaB-mediated transcription by interacting with the transactivation domain of the p65 subunit.</title>
<authorList>
<person name="Asamitsu K."/>
<person name="Tetsuka T."/>
<person name="Kanazawa S."/>
<person name="Okamoto T."/>
</authorList>
<dbReference type="PubMed" id="12748188"/>
<dbReference type="DOI" id="10.1074/jbc.m211831200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH RNF25</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="39583" last="39590">
<title>Glycogen synthase kinase-3 beta regulates NF-kappa B1/p105 stability.</title>
<authorList>
<person name="Demarchi F."/>
<person name="Bertoli C."/>
<person name="Sandy P."/>
<person name="Schneider C."/>
</authorList>
<dbReference type="PubMed" id="12871932"/>
<dbReference type="DOI" id="10.1074/jbc.m305676200"/>
</citation>
<scope>INTERACTION WITH GSK3B</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2003" name="Mol. Cell" volume="12" first="1413" last="1426">
<title>Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA.</title>
<authorList>
<person name="Ryo A."/>
<person name="Suizu F."/>
<person name="Yoshida Y."/>
<person name="Perrem K."/>
<person name="Liou Y.C."/>
<person name="Wulf G."/>
<person name="Rottapel R."/>
<person name="Yamaoka S."/>
<person name="Lu K.P."/>
</authorList>
<dbReference type="PubMed" id="14690596"/>
<dbReference type="DOI" id="10.1016/s1097-2765(03)00490-8"/>
</citation>
<scope>PHOSPHORYLATION AT THR-254</scope>
<scope>INTERACTION WITH PIN1 AND SOCS1</scope>
<scope>MUTAGENESIS OF THR-254</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2004" name="Eur. J. Biochem." volume="271" first="3741" last="3751">
<title>RNA helicase A interacts with nuclear factor kappaB p65 and functions as a transcriptional coactivator.</title>
<authorList>
<person name="Tetsuka T."/>
<person name="Uranishi H."/>
<person name="Sanda T."/>
<person name="Asamitsu K."/>
<person name="Yang J.-P."/>
<person name="Wong-Staal F."/>
<person name="Okamoto T."/>
</authorList>
<dbReference type="PubMed" id="15355351"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.2004.04314.x"/>
</citation>
<scope>INTERACTION WITH DHX9</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="17819" last="17825">
<title>Identification of a ZU5 and death domain-containing inhibitor of NF-kappaB.</title>
<authorList>
<person name="Zhang J."/>
<person name="Xu L.-G."/>
<person name="Han K.-J."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="14769797"/>
<dbReference type="DOI" id="10.1074/jbc.m310737200"/>
</citation>
<scope>INTERACTION WITH UNC5CL</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="26143" last="26148">
<title>Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappaB activation by protein phosphatase 4-mediated NF-kappaB p65 Thr dephosphorylation.</title>
<authorList>
<person name="Yeh P.Y."/>
<person name="Yeh K.H."/>
<person name="Chuang S.E."/>
<person name="Song Y.C."/>
<person name="Cheng A.L."/>
</authorList>
<dbReference type="PubMed" id="15073167"/>
<dbReference type="DOI" id="10.1074/jbc.m402362200"/>
</citation>
<scope>PHOSPHORYLATION AT THR-435</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2004" name="J. Exp. Med." volume="200" first="107" last="113">
<title>Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response.</title>
<authorList>
<person name="Saccani S."/>
<person name="Marazzi I."/>
<person name="Beg A.A."/>
<person name="Natoli G."/>
</authorList>
<dbReference type="PubMed" id="15226358"/>
<dbReference type="DOI" id="10.1084/jem.20040196"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2004" name="Mol. Cell" volume="14" first="303" last="317">
<title>Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways.</title>
<authorList>
<person name="Gao H."/>
<person name="Sun Y."/>
<person name="Wu Y."/>
<person name="Luan B."/>
<person name="Wang Y."/>
<person name="Qu B."/>
<person name="Pei G."/>
</authorList>
<dbReference type="PubMed" id="15125834"/>
<dbReference type="DOI" id="10.1016/s1097-2765(04)00216-3"/>
</citation>
<scope>INTERACTION WITH ARRB2</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2004" name="Nature" volume="428" first="328" last="332">
<title>The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis.</title>
<authorList>
<person name="Garkavtsev I."/>
<person name="Kozin S.V."/>
<person name="Chernova O."/>
<person name="Xu L."/>
<person name="Winkler F."/>
<person name="Brown E."/>
<person name="Barnett G.H."/>
<person name="Jain R.K."/>
</authorList>
<dbReference type="PubMed" id="15029197"/>
<dbReference type="DOI" id="10.1038/nature02329"/>
</citation>
<scope>INTERACTION WITH ING4</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2005" name="EMBO J." volume="24" first="1157" last="1169">
<title>Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor.</title>
<authorList>
<person name="Rocha S."/>
<person name="Garrett M.D."/>
<person name="Campbell K.J."/>
<person name="Schumm K."/>
<person name="Perkins N.D."/>
</authorList>
<dbReference type="PubMed" id="15775976"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600608"/>
</citation>
<scope>PHOSPHORYLATION AT THR-505</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2005" name="FASEB J." volume="19" first="1758" last="1760">
<title>IKKbeta phosphorylates p65 at S468 in transactivation domain 2.</title>
<authorList>
<person name="Schwabe R.F."/>
<person name="Sakurai H."/>
</authorList>
<dbReference type="PubMed" id="16046471"/>
<dbReference type="DOI" id="10.1096/fj.05-3736fje"/>
</citation>
<scope>PHOSPHORYLATION AT SER-468</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="244" last="252">
<title>cis-acting, element-specific transcriptional activity of differentially phosphorylated nuclear factor-kappa B.</title>
<authorList>
<person name="Anrather J."/>
<person name="Racchumi G."/>
<person name="Iadecola C."/>
</authorList>
<dbReference type="PubMed" id="15516339"/>
<dbReference type="DOI" id="10.1074/jbc.m409344200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-281</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="22222" last="22232">
<title>COMMD proteins, a novel family of structural and functional homologs of MURR1.</title>
<authorList>
<person name="Burstein E."/>
<person name="Hoberg J.E."/>
<person name="Wilkinson A.S."/>
<person name="Rumble J.M."/>
<person name="Csomos R.A."/>
<person name="Komarck C.M."/>
<person name="Maine G.N."/>
<person name="Wilkinson J.C."/>
<person name="Mayo M.W."/>
<person name="Duckett C.S."/>
</authorList>
<dbReference type="PubMed" id="15799966"/>
<dbReference type="DOI" id="10.1074/jbc.m501928200"/>
</citation>
<scope>INTERACTION WITH COMMD1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="7966" last="7975">
<title>NF-kappaB RelA phosphorylation regulates RelA acetylation.</title>
<authorList>
<person name="Chen L.F."/>
<person name="Williams S.A."/>
<person name="Mu Y."/>
<person name="Nakano H."/>
<person name="Duerr J.M."/>
<person name="Buckbinder L."/>
<person name="Greene W.C."/>
</authorList>
<dbReference type="PubMed" id="16135789"/>
<dbReference type="DOI" id="10.1128/mcb.25.18.7966-7975.2005"/>
</citation>
<scope>ACETYLATION AT LYS-310</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="5138" last="5143">
<title>Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells.</title>
<authorList>
<person name="Bettelli E."/>
<person name="Dastrange M."/>
<person name="Oukka M."/>
</authorList>
<dbReference type="PubMed" id="15790681"/>
<dbReference type="DOI" id="10.1073/pnas.0501675102"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FOXP3</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2005" name="Virology" volume="331" first="260" last="268">
<title>Respiratory syncytial virus M2-1 protein induces the activation of nuclear factor kappa B.</title>
<authorList>
<person name="Reimers K."/>
<person name="Buchholz K."/>
<person name="Werchau H."/>
</authorList>
<dbReference type="PubMed" id="15629770"/>
<dbReference type="DOI" id="10.1016/j.virol.2004.10.031"/>
</citation>
<scope>INTERACTION WITH HRSV PROTEIN M2-1 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2006" name="Cancer Res." volume="66" first="1509" last="1516">
<title>Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis.</title>
<authorList>
<person name="Emdad L."/>
<person name="Sarkar D."/>
<person name="Su Z.-Z."/>
<person name="Randolph A."/>
<person name="Boukerche H."/>
<person name="Valerie K."/>
<person name="Fisher P.B."/>
</authorList>
<dbReference type="PubMed" id="16452207"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-05-3029"/>
</citation>
<scope>INTERACTION WITH MTDH</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2006" name="Cell. Signal." volume="18" first="83" last="92">
<title>Human ubiquitin specific protease 31 is a deubiquitinating enzyme implicated in activation of nuclear factor-kappaB.</title>
<authorList>
<person name="Tzimas C."/>
<person name="Michailidou G."/>
<person name="Arsenakis M."/>
<person name="Kieff E."/>
<person name="Mosialos G."/>
<person name="Hatzivassiliou E.G."/>
</authorList>
<dbReference type="PubMed" id="16214042"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2005.03.017"/>
</citation>
<scope>INTERACTION WITH USP48</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="6175" last="6183">
<title>Inducible phosphorylation of NF-kappa B p65 at serine 468 by T cell costimulation is mediated by IKK epsilon.</title>
<authorList>
<person name="Mattioli I."/>
<person name="Geng H."/>
<person name="Sebald A."/>
<person name="Hodel M."/>
<person name="Bucher C."/>
<person name="Kracht M."/>
<person name="Schmitz M.L."/>
</authorList>
<dbReference type="PubMed" id="16407239"/>
<dbReference type="DOI" id="10.1074/jbc.m508045200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-468</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="8683" last="8696">
<title>Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis.</title>
<authorList>
<person name="Liu Y."/>
<person name="Smith P.W."/>
<person name="Jones D.R."/>
</authorList>
<dbReference type="PubMed" id="17000776"/>
<dbReference type="DOI" id="10.1128/mcb.00940-06"/>
</citation>
<scope>INTERACTION WITH BRMS1</scope>
<scope>FUNCTION</scope>
<scope>ACETYLATION AT LYS-310</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2006" name="Mol. Endocrinol." volume="20" first="1562" last="1573">
<title>Coactivator-associated arginine methyltransferase-1 enhances nuclear factor-kappaB-mediated gene transcription through methylation of histone H3 at arginine 17.</title>
<authorList>
<person name="Miao F."/>
<person name="Li S."/>
<person name="Chavez V."/>
<person name="Lanting L."/>
<person name="Natarajan R."/>
</authorList>
<dbReference type="PubMed" id="16497732"/>
<dbReference type="DOI" id="10.1210/me.2005-0365"/>
</citation>
<scope>INTERACTION WITH CARM1</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="2689" last="2694">
<title>IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.</title>
<authorList>
<person name="Song Y.J."/>
<person name="Jen K.Y."/>
<person name="Soni V."/>
<person name="Kieff E."/>
<person name="Cahir-McFarland E."/>
</authorList>
<dbReference type="PubMed" id="16477006"/>
<dbReference type="DOI" id="10.1073/pnas.0511096103"/>
</citation>
<scope>IDENTIFICATION IN THE NF-KAPPA-B P65-P52 COMPLEX</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2007" name="Cancer Cell" volume="12" first="239" last="251">
<title>LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB.</title>
<authorList>
<person name="Wang J."/>
<person name="An H."/>
<person name="Mayo M.W."/>
<person name="Baldwin A.S."/>
<person name="Yarbrough W.G."/>
</authorList>
<dbReference type="PubMed" id="17785205"/>
<dbReference type="DOI" id="10.1016/j.ccr.2007.07.002"/>
</citation>
<scope>INTERACTION WITH CDK5RAP3; HDAC1; HDAC2 AND HADC3</scope>
<scope>PHOSPHORYLATION AT SER-536</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2007" name="Genomics" volume="89" first="756" last="768">
<title>Nine-amino-acid transactivation domain: establishment and prediction utilities.</title>
<authorList>
<person name="Piskacek S."/>
<person name="Gregor M."/>
<person name="Nemethova M."/>
<person name="Grabner M."/>
<person name="Kovarik P."/>
<person name="Piskacek M."/>
</authorList>
<dbReference type="PubMed" id="17467953"/>
<dbReference type="DOI" id="10.1016/j.ygeno.2007.02.003"/>
</citation>
<scope>DOMAIN</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2007" name="J. Cell Biol." volume="178" first="231" last="244">
<title>UXT is a novel and essential cofactor in the NF-kappaB transcriptional enhanceosome.</title>
<authorList>
<person name="Sun S."/>
<person name="Tang Y."/>
<person name="Lou X."/>
<person name="Zhu L."/>
<person name="Yang K."/>
<person name="Zhang B."/>
<person name="Shi H."/>
<person name="Wang C."/>
</authorList>
<dbReference type="PubMed" id="17620405"/>
<dbReference type="DOI" id="10.1083/jcb.200611081"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH UXT</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2008" name="Blood" volume="112" first="1794" last="1803">
<title>The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment.</title>
<authorList>
<person name="Chae J.J."/>
<person name="Wood G."/>
<person name="Richard K."/>
<person name="Jaffe H."/>
<person name="Colburn N.T."/>
<person name="Masters S.L."/>
<person name="Gumucio D.L."/>
<person name="Shoham N.G."/>
<person name="Kastner D.L."/>
</authorList>
<dbReference type="PubMed" id="18577712"/>
<dbReference type="DOI" id="10.1182/blood-2008-01-134932"/>
</citation>
<scope>INTERACTION WITH MEFV</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2008" name="J. Allergy Clin. Immunol." volume="121" first="1148" last="1154">
<title>Functional characterization of the atopy-associated gene PHF11.</title>
<authorList>
<person name="Clarke E."/>
<person name="Rahman N."/>
<person name="Page N."/>
<person name="Rolph M.S."/>
<person name="Stewart G.J."/>
<person name="Jones G.J."/>
</authorList>
<dbReference type="PubMed" id="18405956"/>
<dbReference type="DOI" id="10.1016/j.jaci.2008.02.028"/>
</citation>
<scope>INTERACTION WITH PHF11</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="7834" last="7843">
<title>AKIP1 enhances NF-kappaB-dependent gene expression by promoting the nuclear retention and phosphorylation of p65.</title>
<authorList>
<person name="Gao N."/>
<person name="Asamitsu K."/>
<person name="Hibi Y."/>
<person name="Ueno T."/>
<person name="Okamoto T."/>
</authorList>
<dbReference type="PubMed" id="18178962"/>
<dbReference type="DOI" id="10.1074/jbc.m710285200"/>
</citation>
<scope>INTERACTION WITH AKIP1</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2008" name="Oncogene" volume="27" first="3516" last="3526">
<title>Copine-I represses NF-kappaB transcription by endoproteolysis of p65.</title>
<authorList>
<person name="Ramsey C.S."/>
<person name="Yeung F."/>
<person name="Stoddard P.B."/>
<person name="Li D."/>
<person name="Creutz C.E."/>
<person name="Mayo M.W."/>
</authorList>
<dbReference type="PubMed" id="18212740"/>
<dbReference type="DOI" id="10.1038/sj.onc.1211030"/>
</citation>
<scope>INTERACTION WITH CPEN1</scope>
<scope>PROTEOLYTIC CLEAVAGE</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2009" name="J. Cell. Biochem." volume="106" first="296" last="305">
<title>The DEAD-box RNA helicase DDX1 interacts with RelA and enhances nuclear factor kappaB-mediated transcription.</title>
<authorList>
<person name="Ishaq M."/>
<person name="Ma L."/>
<person name="Wu X."/>
<person name="Mu Y."/>
<person name="Pan J."/>
<person name="Hu J."/>
<person name="Hu T."/>
<person name="Fu Q."/>
<person name="Guo D."/>
</authorList>
<dbReference type="PubMed" id="19058135"/>
<dbReference type="DOI" id="10.1002/jcb.22004"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH DDX1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2009" name="Mol. Cell. Biol." volume="29" first="1375" last="1387">
<title>Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA.</title>
<authorList>
<person name="Huang B."/>
<person name="Yang X.D."/>
<person name="Zhou M.M."/>
<person name="Ozato K."/>
<person name="Chen L.F."/>
</authorList>
<dbReference type="PubMed" id="19103749"/>
<dbReference type="DOI" id="10.1128/mcb.01365-08"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH BRD4</scope>
<scope>ACETYLATION AT LYS-310</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-310</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="12232" last="12240">
<title>A novel LZAP-binding protein, NLBP, inhibits cell invasion.</title>
<authorList>
<person name="Kwon J."/>
<person name="Cho H.J."/>
<person name="Han S.H."/>
<person name="No J.G."/>
<person name="Kwon J.Y."/>
<person name="Kim H."/>
</authorList>
<dbReference type="PubMed" id="20164180"/>
<dbReference type="DOI" id="10.1074/jbc.m109.065920"/>
</citation>
<scope>INTERACTION WITH UFL1</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2010" name="J. Cell Sci." volume="123" first="4251" last="4258">
<title>SIRT2 regulates NF-kappaB dependent gene expression through deacetylation of p65 Lys310.</title>
<authorList>
<person name="Rothgiesser K.M."/>
<person name="Erener S."/>
<person name="Waibel S."/>
<person name="Luscher B."/>
<person name="Hottiger M.O."/>
</authorList>
<dbReference type="PubMed" id="21081649"/>
<dbReference type="DOI" id="10.1242/jcs.073783"/>
</citation>
<scope>DEACETYLATION BY SIRT2</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2010" name="Mol. Cell. Biol." volume="30" first="3929" last="3942">
<title>Zinc finger protein Gfi1 controls the endotoxin-mediated Toll-like receptor inflammatory response by antagonizing NF-kappaB p65.</title>
<authorList>
<person name="Sharif-Askari E."/>
<person name="Vassen L."/>
<person name="Kosan C."/>
<person name="Khandanpour C."/>
<person name="Gaudreau M.C."/>
<person name="Heyd F."/>
<person name="Okayama T."/>
<person name="Jin J."/>
<person name="Rojas M.E."/>
<person name="Grimes H.L."/>
<person name="Zeng H."/>
<person name="Moroy T."/>
</authorList>
<dbReference type="PubMed" id="20547752"/>
<dbReference type="DOI" id="10.1128/mcb.00087-10"/>
</citation>
<scope>INTERACTION WITH GFI1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="17333" last="17338">
<title>The Listeria monocytogenes InlC protein interferes with innate immune responses by targeting the I{kappa}B kinase subunit IKK{alpha}.</title>
<authorList>
<person name="Gouin E."/>
<person name="Adib-Conquy M."/>
<person name="Balestrino D."/>
<person name="Nahori M.A."/>
<person name="Villiers V."/>
<person name="Colland F."/>
<person name="Dramsi S."/>
<person name="Dussurget O."/>
<person name="Cossart P."/>
</authorList>
<dbReference type="PubMed" id="20855622"/>
<dbReference type="DOI" id="10.1073/pnas.1007765107"/>
</citation>
<scope>SUBCELLULAR LOCATION (MICROBIAL INFECTION)</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2011" name="J. Virol." volume="85" first="8606" last="8615">
<title>Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen reduces interleukin-8 expression in endothelial cells and impairs neutrophil chemotaxis by degrading nuclear p65.</title>
<authorList>
<person name="Li X."/>
<person name="Liang D."/>
<person name="Lin X."/>
<person name="Robertson E.S."/>
<person name="Lan K."/>
</authorList>
<dbReference type="PubMed" id="21697472"/>
<dbReference type="DOI" id="10.1128/jvi.00733-11"/>
</citation>
<scope>INTERACTION WITH HERPES VIRUS 8 PROTEIN LANA1 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E37636" last="E37636">
<title>NF-kappaB repression by PIAS3 mediated RelA SUMOylation.</title>
<authorList>
<person name="Liu Y."/>
<person name="Bridges R."/>
<person name="Wortham A."/>
<person name="Kulesz-Martin M."/>
</authorList>
<dbReference type="PubMed" id="22649547"/>
<dbReference type="DOI" id="10.1371/journal.pone.0037636"/>
</citation>
<scope>SUMOYLATION AT LYS-37; LYS-122 AND LYS-123 BY PIAS3</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2014" name="Nature" volume="506" first="451" last="455">
<title>C11orf95-RELA fusions drive oncogenic NF-kappaB signalling in ependymoma.</title>
<authorList>
<person name="Parker M."/>
<person name="Mohankumar K.M."/>
<person name="Punchihewa C."/>
<person name="Weinlich R."/>
<person name="Dalton J.D."/>
<person name="Li Y."/>
<person name="Lee R."/>
<person name="Tatevossian R.G."/>
<person name="Phoenix T.N."/>
<person name="Thiruvenkatam R."/>
<person name="White E."/>
<person name="Tang B."/>
<person name="Orisme W."/>
<person name="Gupta K."/>
<person name="Rusch M."/>
<person name="Chen X."/>
<person name="Li Y."/>
<person name="Nagahawhatte P."/>
<person name="Hedlund E."/>
<person name="Finkelstein D."/>
<person name="Wu G."/>
<person name="Shurtleff S."/>
<person name="Easton J."/>
<person name="Boggs K."/>
<person name="Yergeau D."/>
<person name="Vadodaria B."/>
<person name="Mulder H.L."/>
<person name="Becksfort J."/>
<person name="Becksford J."/>
<person name="Gupta P."/>
<person name="Huether R."/>
<person name="Ma J."/>
<person name="Song G."/>
<person name="Gajjar A."/>
<person name="Merchant T."/>
<person name="Boop F."/>
<person name="Smith A.A."/>
<person name="Ding L."/>
<person name="Lu C."/>
<person name="Ochoa K."/>
<person name="Zhao D."/>
<person name="Fulton R.S."/>
<person name="Fulton L.L."/>
<person name="Mardis E.R."/>
<person name="Wilson R.K."/>
<person name="Downing J.R."/>
<person name="Green D.R."/>
<person name="Zhang J."/>
<person name="Ellison D.W."/>
<person name="Gilbertson R.J."/>
</authorList>
<dbReference type="PubMed" id="24553141"/>
<dbReference type="DOI" id="10.1038/nature13109"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH C11ORF95</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2015" name="J. Virol." volume="89" first="8406" last="8415">
<title>Poxvirus protein MC132 from molluscum contagiosum virus inhibits NF-B activation by targeting p65 for degradation.</title>
<authorList>
<person name="Brady G."/>
<person name="Haas D.A."/>
<person name="Farrell P.J."/>
<person name="Pichlmair A."/>
<person name="Bowie A.G."/>
</authorList>
<dbReference type="PubMed" id="26041281"/>
<dbReference type="DOI" id="10.1128/jvi.00799-15"/>
</citation>
<scope>INTERACTION WITH MOLLUSCUM CONTAGIOSUM VIRUS PROTEIN MC132 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2016" name="PLoS ONE" volume="11" first="E0164471" last="E0164471">
<title>The DEAD-Box RNA Helicase DDX3 Interacts with NF-kappaB Subunit p65 and Suppresses p65-Mediated Transcription.</title>
<authorList>
<person name="Xiang N."/>
<person name="He M."/>
<person name="Ishaq M."/>
<person name="Gao Y."/>
<person name="Song F."/>
<person name="Guo L."/>
<person name="Ma L."/>
<person name="Sun G."/>
<person name="Liu D."/>
<person name="Guo D."/>
<person name="Chen Y."/>
</authorList>
<dbReference type="PubMed" id="27736973"/>
<dbReference type="DOI" id="10.1371/journal.pone.0164471"/>
</citation>
<scope>INTERACTION WITH DDX3X</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2017" name="J. Exp. Med." volume="214" first="1937" last="1947">
<title>Human RELA haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulceration.</title>
<authorList>
<person name="Badran Y.R."/>
<person name="Dedeoglu F."/>
<person name="Leyva Castillo J.M."/>
<person name="Bainter W."/>
<person name="Ohsumi T.K."/>
<person name="Bousvaros A."/>
<person name="Goldsmith J.D."/>
<person name="Geha R.S."/>
<person name="Chou J."/>
</authorList>
<dbReference type="PubMed" id="28600438"/>
<dbReference type="DOI" id="10.1084/jem.20160724"/>
</citation>
<scope>INVOLVEMENT IN CMCU</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2017" name="Sci. Rep." volume="7" first="13448" last="13448">
<title>LRRC25 functions as an inhibitor of NF-kappaB signaling pathway by promoting p65/RelA for autophagic degradation.</title>
<authorList>
<person name="Feng Y."/>
<person name="Duan T."/>
<person name="Du Y."/>
<person name="Jin S."/>
<person name="Wang M."/>
<person name="Cui J."/>
<person name="Wang R.F."/>
</authorList>
<dbReference type="PubMed" id="29044191"/>
<dbReference type="DOI" id="10.1038/s41598-017-12573-3"/>
</citation>
<scope>INTERACTION WITH LRRC25</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2018" name="PLoS Biol." volume="16" first="E2004526" last="E2004526">
<title>Zbtb7a is a transducer for the control of promoter accessibility by NF-kappa B and multiple other transcription factors.</title>
<authorList>
<person name="Ramos Pittol J.M."/>
<person name="Oruba A."/>
<person name="Mittler G."/>
<person name="Saccani S."/>
<person name="van Essen D."/>
</authorList>
<dbReference type="PubMed" id="29813070"/>
<dbReference type="DOI" id="10.1371/journal.pbio.2004526"/>
</citation>
<scope>INTERACTION WITH ZBTB7A</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2019" name="FEBS Lett.">
<title>The E3 ubiquitin ligase RNF182 inhibits TLR-triggered cytokine production through promoting p65 ubiquitination and degradation.</title>
<authorList>
<person name="Cao Y."/>
<person name="Sun Y."/>
<person name="Chang H."/>
<person name="Sun X."/>
<person name="Yang S."/>
</authorList>
<dbReference type="PubMed" id="31432514"/>
<dbReference type="DOI" id="10.1002/1873-3468.13583"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="72">
<citation type="journal article" date="1998" name="Cell" volume="95" first="749" last="758">
<title>Structure of an IkappaBalpha/NF-kappaB complex.</title>
<authorList>
<person name="Jacobs M.D."/>
<person name="Harrison S.C."/>
</authorList>
<dbReference type="PubMed" id="9865693"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)81698-0"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS)</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2018" name="J. Allergy Clin. Immunol." volume="141" first="1507" last="1510">
<title>RELA haploinsufficiency in CD4 lymphoproliferative disease with autoimmune cytopenias.</title>
<authorList>
<person name="Comrie W.A."/>
<person name="Faruqi A.J."/>
<person name="Price S."/>
<person name="Zhang Y."/>
<person name="Rao V.K."/>
<person name="Su H.C."/>
<person name="Lenardo M.J."/>
</authorList>
<dbReference type="PubMed" id="29305315"/>
<dbReference type="DOI" id="10.1016/j.jaci.2017.11.036"/>
</citation>
<scope>VARIANT 246-ARG--SER-549 DEL</scope>
</reference>
<comment type="function">
<text evidence="11 17 26 31 34 37 38 39">NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The heterodimeric RELA-NFKB1 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. The NF-kappa-B heterodimeric RELA-NFKB1 and RELA-REL complexes, for instance, function as transcriptional activators. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. The inhibitory effect of I-kappa-B on NF-kappa-B through retention in the cytoplasm is exerted primarily through the interaction with RELA. RELA shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-B complex. Beside its activity as a direct transcriptional activator, it is also able to modulate promoters accessibility to transcription factors and thereby indirectly regulate gene expression. Associates with chromatin at the NF-kappa-B promoter region via association with DDX1. Essential for cytokine gene expression in T-cells (PubMed:15790681). The NF-kappa-B homodimeric RELA-RELA complex appears to be involved in invasin-mediated activation of IL-8 expression.</text>
</comment>
<comment type="subunit">
<text evidence="7 19 22 26 35 36 45 47 49">Component of the NF-kappa-B p65-p50 complex. Component of the NF-kappa-B p65-c-Rel complex. Homodimer; component of the NF-kappa-B p65-p65 complex. Component of the NF-kappa-B p65-p52 complex. May interact with ETHE1. Binds TLE5 and TLE1. Interacts with TP53BP2. Binds to and is phosphorylated by the activated form of either RPS6KA4 or RPS6KA5. Interacts with ING4 and this interaction may be indirect. Interacts with CARM1, USP48 and UNC5CL. Interacts with IRAK1BP1 (By similarity). Interacts with NFKBID (By similarity). Interacts with NFKBIA (PubMed:1493333). Interacts with GSK3B. Interacts with NFKBIB (By similarity). Interacts with NFKBIE. Interacts with NFKBIZ. Interacts with EHMT1 (via ANK repeats) (By similarity). Part of a 70-90 kDa complex at least consisting of CHUK, IKBKB, NFKBIA, RELA, ELP1 and MAP3K14. Interacts with HDAC3; HDAC3 mediates the deacetylation of RELA. Interacts with HDAC1; the interaction requires non-phosphorylated RELA. Interacts with CBP; the interaction requires phosphorylated RELA. Interacts (phosphorylated at 'Thr-254') with PIN1; the interaction inhibits p65 binding to NFKBIA. Interacts with SOCS1. Interacts with UXT. Interacts with MTDH and PHF11. Interacts with ARRB2. Interacts with NFKBIA (when phosphorylated), the interaction is direct; phosphorylated NFKBIA is part of a SCF(BTRC)-like complex lacking CUL1. Interacts with RNF25. Interacts (via C-terminus) with DDX1. Interacts with UFL1 and COMMD1. Interacts with BRMS1; this promotes deacetylation of 'Lys-310'. Interacts with NOTCH2 (By similarity). Directly interacts with MEN1; this interaction represses NFKB-mediated transactivation. Interacts with AKIP1, which promotes the phosphorylation and nuclear retention of RELA. Interacts (via the RHD) with GFI1; the interaction, after bacterial lipopolysaccharide (LPS) stimulation, inhibits the transcriptional activity by interfering with the DNA-binding activity to target gene promoter DNA. Interacts (when acetylated at Lys-310) with BRD4; leading to activation of the NF-kappa-B pathway. Interacts with MEFV. Interacts with CLOCK (By similarity). Interacts (via N-terminus) with CPEN1; this interaction induces proteolytic cleavage of p65/RELA subunit and inhibition of NF-kappa-B transcriptional activity (PubMed:18212740). Interacts with FOXP3. Interacts with CDK5RAP3; stimulates the interaction of RELA with HDAC1, HDAC2 and HDAC3 thereby inhibiting NF-kappa-B transcriptional activity (PubMed:17785205). Interacts with DHX9; this interaction is direct and activates NF-kappa-B-mediated transcription (PubMed:15355351). Interacts with LRRC25 (PubMed:29044191). Interacts with TBX21 (By similarity). Interacts with KAT2A (By similarity). Interacts with ZBTB7A; involved in the control by RELA of the accessibility of target gene promoters (PubMed:29813070). Directly interacts with DDX3X; this interaction may trap RELA in the cytoplasm, impairing nuclear relocalization upon TNF activating signals (PubMed:27736973).</text>
</comment>
<comment type="subunit">
<text evidence="24">(Microbial infection) Interacts with human respiratory syncytial virus (HRSV) protein M2-1.</text>
</comment>
<comment type="subunit">
<text evidence="44">(Microbial infection) Interacts with molluscum contagiosum virus MC132.</text>
</comment>
<comment type="subunit">
<text evidence="41">(Microbial infection) Interacts with herpes virus 8 virus protein LANA1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-372428">
<id>Q9NY61</id>
<label>AATF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-9844134">
<id>P18847-3</id>
<label>ATF3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-723869">
<id>O60885</id>
<label>BRD4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-718818">
<id>Q96JB5</id>
<label>CDK5RAP3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-81249">
<id>O15111</id>
<label>CHUK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-1550112">
<id>Q8N668</id>
<label>COMMD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-81215">
<id>Q92793</id>
<label>CREBBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-947590">
<id>P52943</id>
<label>CRIP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-491549">
<id>P35222</id>
<label>CTNNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-77321">
<id>Q9UER7</id>
<label>DAXX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-352022">
<id>Q08211</id>
<label>DHX9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-766087">
<id>Q9H9B1</id>
<label>EHMT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-78473">
<id>P03372</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-949368">
<id>Q99684</id>
<label>GFI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-301834">
<id>Q13547</id>
<label>HDAC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-1748945">
<id>P46695</id>
<label>IER3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-81266">
<id>O14920</id>
<label>IKBKB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-3931258">
<id>Q13568</id>
<label>IRF5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-765758">
<id>Q9Y2K7</id>
<label>KDM2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-751001">
<id>Q14145</id>
<label>KEAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-714994">
<id>Q99612</id>
<label>KLF6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-739696">
<id>P25791</id>
<label>LMO2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-5324932">
<id>Q9BQ69</id>
<label>MACROD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-713543">
<id>P53779</id>
<label>MAPK10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-9869387">
<id>O00255-2</id>
<label>MEN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-300010">
<id>P19838</id>
<label>NFKB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-697771">
<id>PRO_0000030311</id>
<label>NFKB1</label>
<dbReference type="UniProtKB" id="P19838"/>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-307386">
<id>P25963</id>
<label>NFKBIA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>24</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-352889">
<id>Q15653</id>
<label>NFKBIB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-16085263">
<id>P22736-1</id>
<label>NR4A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-2862434">
<id>Q96L73</id>
<label>NSD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-539828">
<id>O15294</id>
<label>OGT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-935824">
<id>Q53EL6</id>
<label>PDCD4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-473160">
<id>Q8N2W9</id>
<label>PIAS4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-712311">
<id>P67775</id>
<label>PPP2CA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-302388">
<id>P30153</id>
<label>PPP2R1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-73886">
<id>Q04206</id>
<label>RELA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-357837">
<id>Q01201</id>
<label>RELB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-351193">
<id>P23396</id>
<label>RPS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-73869">
<id>O75582</id>
<label>RPS6KA5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-1268586">
<id>Q8WTS6</id>
<label>SETD7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
<label>SIRT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-477232">
<id>Q8IXJ6</id>
<label>SIRT2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-712415">
<id>Q8N6T7</id>
<label>SIRT6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-1045459">
<id>O95863</id>
<label>SNAI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-968198">
<id>O15524</id>
<label>SOCS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-518675">
<id>P40763</id>
<label>STAT3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-372899">
<id>Q13148</id>
<label>TARDBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-727668">
<id>P21980</id>
<label>TGM2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-77642">
<id>Q13625</id>
<label>TP53BP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-287091">
<id>Q13625-2</id>
<label>TP53BP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-3390054">
<id>P0CG48</id>
<label>UBC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-357355">
<id>Q9UBK9</id>
<label>UXT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-6260864">
<id>Q9ESU6</id>
<label>Brd4</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-6933128">
<id>O41974</id>
<label>GAMMAHV.ORF73</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-15626132">
<id>Q8VIM5-1</id>
<label>Myocd</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-10039193">
<id>Q8X834</id>
<label>nleC</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-3650423">
<id>P0C774</id>
<label>P/V</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-1029310">
<id>P10226</id>
<label>UL42</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-2840013">
<id>P31491</id>
<label>yerA</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-20592225">
<id>A0A384KL23</id>
<label>YPO2940</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-20592206">
<id>A0A384L2L7</id>
<label>YPO3877</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-73886">
<id>Q04206</id>
</interactant>
<interactant intactId="EBI-2846298">
<id>P69976</id>
<label>yscL</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-10826776">
<id>Q04206-1</id>
</interactant>
<interactant intactId="EBI-12695166">
<id>Q9NPC8</id>
<label>SIX2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-10826776">
<id>Q04206-1</id>
</interactant>
<interactant intactId="EBI-15626132">
<id>Q8VIM5-1</id>
<label>Myocd</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-289947">
<id>Q04206-2</id>
</interactant>
<interactant intactId="EBI-307386">
<id>P25963</id>
<label>NFKBIA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-289947">
<id>Q04206-2</id>
</interactant>
<interactant intactId="EBI-307352">
<id>Q04864</id>
<label>REL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-289947">
<id>Q04206-2</id>
</interactant>
<interactant intactId="EBI-357837">
<id>Q01201</id>
<label>RELB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-10223388">
<id>Q04206-3</id>
</interactant>
<interactant intactId="EBI-307352">
<id>Q04864</id>
<label>REL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-10223388">
<id>Q04206-3</id>
</interactant>
<interactant intactId="EBI-533224">
<id>P15884</id>
<label>TCF4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="19 27 37 39">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19 37 39 45">Cytoplasm</location>
</subcellularLocation>
<text evidence="19 37 39 40">Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B) (PubMed:1493333). Colocalized with DDX1 in the nucleus upon TNF-alpha induction (PubMed:19058135). Colocalizes with GFI1 in the nucleus after LPS stimulation (PubMed:20547752). Translocation to the nucleus is impaired in L.monocytogenes infection (PubMed:20855622).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q04206-1</id>
<name>1</name>
<name>p65</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q04206-2</id>
<name>2</name>
<name>p65 delta 2</name>
<sequence type="described" ref="VSP_005587 VSP_005588"/>
</isoform>
<isoform>
<id>Q04206-3</id>
<name>3</name>
<name>p65 delta</name>
<sequence type="described" ref="VSP_012031"/>
</isoform>
<isoform>
<id>Q04206-4</id>
<name>4</name>
<sequence type="described" ref="VSP_031245"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="7">The transcriptional activation domain 3/TA3 does not participate in the direct transcriptional activity of RELA but is involved in the control by RELA of the accessibility of target gene promoters. Mediates interaction with ZBTB7A.</text>
</comment>
<comment type="domain">
<text evidence="7 33">The transcriptional activation domain 1/TA1 and the transcriptional activation domain 2/TA2 have direct transcriptional activation properties (By similarity). The 9aaTAD motif found within the transcriptional activation domain 2 is a conserved motif present in a large number of transcription factors that is required for their transcriptional transactivation activity (PubMed:17467953).</text>
</comment>
<comment type="PTM">
<text evidence="21 50">Ubiquitinated by RNF182, leading to its proteasomal degradation. Degradation is required for termination of NF-kappa-B response.</text>
</comment>
<comment type="PTM">
<text evidence="6">Monomethylated at Lys-310 by SETD6. Monomethylation at Lys-310 is recognized by the ANK repeats of EHMT1 and promotes the formation of repressed chromatin at target genes, leading to down-regulation of NF-kappa-B transcription factor activity. Phosphorylation at Ser-311 disrupts the interaction with EHMT1 without preventing monomethylation at Lys-310 and relieves the repression of target genes (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="6 10 12 13 15 16 18 20 23 25 28 29 30 31 38">Phosphorylation at Ser-311 disrupts the interaction with EHMT1 and promotes transcription factor activity (By similarity). Phosphorylation on Ser-536 stimulates acetylation on Lys-310 and interaction with CBP; the phosphorylated and acetylated forms show enhanced transcriptional activity. Phosphorylation at Ser-276 by RPS6KA4 and RPS6KA5 promotes its transactivation and transcriptional activities.</text>
</comment>
<comment type="PTM">
<text evidence="14 15 29 31 38">Reversibly acetylated; the acetylation seems to be mediated by CBP, the deacetylation by HDAC3 and SIRT2. Acetylation at Lys-122 enhances DNA binding and impairs association with NFKBIA. Acetylation at Lys-310 is required for full transcriptional activity in the absence of effects on DNA binding and NFKBIA association. Acetylation at Lys-310 promotes interaction with BRD4. Acetylation can also lower DNA-binding and results in nuclear export. Interaction with BRMS1 promotes deacetylation of Lys-310. Lys-310 is deacetylated by SIRT2.</text>
</comment>
<comment type="PTM">
<text evidence="6">S-nitrosylation of Cys-38 inactivates the enzyme activity.</text>
</comment>
<comment type="PTM">
<text evidence="6">Sulfhydration at Cys-38 mediates the anti-apoptotic activity by promoting the interaction with RPS3 and activating the transcription factor activity.</text>
</comment>
<comment type="PTM">
<text evidence="42">Sumoylation by PIAS3 negatively regulates DNA-bound activated NF-kappa-B.</text>
</comment>
<comment type="PTM">
<text evidence="36">Proteolytically cleaved within a conserved N-terminus region required for base-specific contact with DNA in a CPEN1-mediated manner, and hence inhibits NF-kappa-B transcriptional activity (PubMed:18212740).</text>
</comment>
<comment type="disease">
<text evidence="43">A chromosomal aberration involving C11orf95 is found in more than two-thirds of supratentorial ependymomas. Translocation with C11orf95 produces a C11orf95-RELA fusion protein. C11orf95-RELA translocations are potent oncogenes that probably transform neural stem cells by driving an aberrant NF-kappa-B transcription program (PubMed:24553141).</text>
</comment>
<comment type="disease" evidence="46">
<disease id="DI-05466">
<name>Mucocutaneous ulceration, chronic</name>
<acronym>CMCU</acronym>
<description>An autosomal dominant, mucocutaneous disease characterized by chronic mucosal lesions, in absence of recurrent infections.</description>
<dbReference type="MIM" id="618287"/>
</disease>
<text>The disease may be caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/RELAID325.html"/>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/rela/"/>
</comment>
<dbReference type="EMBL" id="M62399">
<property type="protein sequence ID" value="AAA36408.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z22948">
<property type="protein sequence ID" value="CAA80524.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z22949">
<property type="protein sequence ID" value="CAA80524.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z22953">
<property type="protein sequence ID" value="CAA80524.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z22950">
<property type="protein sequence ID" value="CAA80524.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z22951">
<property type="protein sequence ID" value="CAA80524.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L19067">
<property type="protein sequence ID" value="AAA20946.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC033522">
<property type="protein sequence ID" value="AAH33522.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY455868">
<property type="protein sequence ID" value="AAR13863.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31609.1">
<molecule id="Q04206-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS44651.1">
<molecule id="Q04206-4"/>
</dbReference>
<dbReference type="PIR" id="A40851">
<property type="entry name" value="A40851"/>
</dbReference>
<dbReference type="PIR" id="I53719">
<property type="entry name" value="I53719"/>
</dbReference>
<dbReference type="PIR" id="S51782">
<property type="entry name" value="A42017"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001138610.1">
<molecule id="Q04206-4"/>
<property type="nucleotide sequence ID" value="NM_001145138.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001230913.1">
<property type="nucleotide sequence ID" value="NM_001243984.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_068810.3">
<molecule id="Q04206-1"/>
<property type="nucleotide sequence ID" value="NM_021975.3"/>
</dbReference>
<dbReference type="PDB" id="1NFI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/C=20-320"/>
</dbReference>
<dbReference type="PDB" id="2LSP">
<property type="method" value="NMR"/>
<property type="chains" value="A=304-316"/>
</dbReference>
<dbReference type="PDB" id="2O61">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=20-291"/>
</dbReference>
<dbReference type="PDB" id="3GUT">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.59"/>
<property type="chains" value="A/C/E/G=20-291"/>
</dbReference>
<dbReference type="PDB" id="3QXY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.09"/>
<property type="chains" value="P/Q=302-316"/>
</dbReference>
<dbReference type="PDB" id="3RC0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.19"/>
<property type="chains" value="P/Q=302-316"/>
</dbReference>
<dbReference type="PDB" id="4KV1">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="C/D=308-314"/>
</dbReference>
<dbReference type="PDB" id="4KV4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="B=308-314"/>
</dbReference>
<dbReference type="PDB" id="5U4K">
<property type="method" value="NMR"/>
<property type="chains" value="B=521-551"/>
</dbReference>
<dbReference type="PDB" id="5URN">
<property type="method" value="NMR"/>
<property type="chains" value="B=521-551"/>
</dbReference>
<dbReference type="PDB" id="6NV2">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.13"/>
<property type="chains" value="P=39-51"/>
</dbReference>
<dbReference type="PDB" id="6QHL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.20"/>
<property type="chains" value="P=38-51"/>
</dbReference>
<dbReference type="PDB" id="6QHM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.25"/>
<property type="chains" value="P=275-287"/>
</dbReference>
<dbReference type="PDBsum" id="1NFI"/>
<dbReference type="PDBsum" id="2LSP"/>
<dbReference type="PDBsum" id="2O61"/>
<dbReference type="PDBsum" id="3GUT"/>
<dbReference type="PDBsum" id="3QXY"/>
<dbReference type="PDBsum" id="3RC0"/>
<dbReference type="PDBsum" id="4KV1"/>
<dbReference type="PDBsum" id="4KV4"/>
<dbReference type="PDBsum" id="5U4K"/>
<dbReference type="PDBsum" id="5URN"/>
<dbReference type="PDBsum" id="6NV2"/>
<dbReference type="PDBsum" id="6QHL"/>
<dbReference type="PDBsum" id="6QHM"/>
<dbReference type="SMR" id="Q04206"/>
<dbReference type="BioGRID" id="111902">
<property type="interactions" value="344"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-5828">
<property type="entry name" value="NF-kappaB DNA-binding transcription factor complex, p50/p65"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-5829">
<property type="entry name" value="NF-kappaB DNA-binding transcription factor complex, p52/p65"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-5834">
<property type="entry name" value="NF-kappaB DNA-binding transcription factor complex, p65/c-Rel"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-5835">
<property type="entry name" value="NF-kappaB DNA-binding transcription factor complex, p65/p65"/>
</dbReference>
<dbReference type="CORUM" id="Q04206"/>
<dbReference type="DIP" id="DIP-24238N"/>
<dbReference type="ELM" id="Q04206"/>
<dbReference type="IntAct" id="Q04206">
<property type="interactions" value="165"/>
</dbReference>
<dbReference type="MINT" id="Q04206"/>
<dbReference type="STRING" id="9606.ENSP00000384273"/>
<dbReference type="BindingDB" id="Q04206"/>
<dbReference type="ChEMBL" id="CHEMBL5533"/>
<dbReference type="DrugBank" id="DB08908">
<property type="generic name" value="Dimethyl fumarate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14059">
<property type="generic name" value="SC-236"/>
</dbReference>
<dbReference type="DrugCentral" id="Q04206"/>
<dbReference type="GlyGen" id="Q04206">
<property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
</dbReference>
<dbReference type="iPTMnet" id="Q04206"/>
<dbReference type="MetOSite" id="Q04206"/>
<dbReference type="PhosphoSitePlus" id="Q04206"/>
<dbReference type="SwissPalm" id="Q04206"/>
<dbReference type="BioMuta" id="RELA"/>
<dbReference type="DMDM" id="62906901"/>
<dbReference type="EPD" id="Q04206"/>
<dbReference type="jPOST" id="Q04206"/>
<dbReference type="MassIVE" id="Q04206"/>
<dbReference type="MaxQB" id="Q04206"/>
<dbReference type="PaxDb" id="Q04206"/>
<dbReference type="PeptideAtlas" id="Q04206"/>
<dbReference type="PRIDE" id="Q04206"/>
<dbReference type="ProteomicsDB" id="58236">
<molecule id="Q04206-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58237">
<molecule id="Q04206-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58238">
<molecule id="Q04206-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58239">
<molecule id="Q04206-4"/>
</dbReference>
<dbReference type="Antibodypedia" id="3557">
<property type="antibodies" value="3634 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="5970"/>
<dbReference type="Ensembl" id="ENST00000308639">
<molecule id="Q04206-4"/>
<property type="protein sequence ID" value="ENSP00000311508"/>
<property type="gene ID" value="ENSG00000173039"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000406246">
<molecule id="Q04206-1"/>
<property type="protein sequence ID" value="ENSP00000384273"/>
<property type="gene ID" value="ENSG00000173039"/>
</dbReference>
<dbReference type="GeneID" id="5970"/>
<dbReference type="KEGG" id="hsa:5970"/>
<dbReference type="UCSC" id="uc001ofg.4">
<molecule id="Q04206-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5970"/>
<dbReference type="DisGeNET" id="5970"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000173039.18"/>
<dbReference type="GeneCards" id="RELA"/>
<dbReference type="HGNC" id="HGNC:9955">
<property type="gene designation" value="RELA"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000173039">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="RELA"/>
<dbReference type="MIM" id="164014">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="618287">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q04206"/>
<dbReference type="OpenTargets" id="ENSG00000173039"/>
<dbReference type="Orphanet" id="251636">
<property type="disease" value="Ependymoma"/>
</dbReference>
<dbReference type="Orphanet" id="530792">
<property type="disease" value="RELA fusion-positive ependymoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA296"/>
<dbReference type="eggNOG" id="ENOG502QT4Z">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000159867"/>
<dbReference type="InParanoid" id="Q04206"/>
<dbReference type="OMA" id="PTAEPML"/>
<dbReference type="OrthoDB" id="916931at2759"/>
<dbReference type="PhylomeDB" id="Q04206"/>
<dbReference type="TreeFam" id="TF325632"/>
<dbReference type="PathwayCommons" id="Q04206"/>
<dbReference type="Reactome" id="R-HSA-1169091">
<property type="pathway name" value="Activation of NF-kappaB in B cells"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1810476">
<property type="pathway name" value="RIP-mediated NFkB activation via ZBP1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-193692">
<property type="pathway name" value="Regulated proteolysis of p75NTR"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202424">
<property type="pathway name" value="Downstream TCR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-209560">
<property type="pathway name" value="NF-kB is activated and signals survival"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559582">
<property type="pathway name" value="Senescence-Associated Secretory Phenotype (SASP)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2871837">
<property type="pathway name" value="FCERI mediated NF-kB activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3134963">
<property type="pathway name" value="DEx/H-box helicases activate type I IFN and inflammatory cytokines production"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3214841">
<property type="pathway name" value="PKMTs methylate histone lysines"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381340">
<property type="pathway name" value="Transcriptional regulation of white adipocyte differentiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-445989">
<property type="pathway name" value="TAK1 activates NFkB by phosphorylation and activation of IKKs complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-448706">
<property type="pathway name" value="Interleukin-1 processing"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4755510">
<property type="pathway name" value="SUMOylation of immune response proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5603029">
<property type="pathway name" value="IkBA variant leads to EDA-ID"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5607761">
<property type="pathway name" value="Dectin-1 mediated noncanonical NF-kB signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5607764">
<property type="pathway name" value="CLEC7A (Dectin-1) signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5621575">
<property type="pathway name" value="CD209 (DC-SIGN) signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5660668">
<property type="pathway name" value="CLEC7A/inflammasome pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-844456">
<property type="pathway name" value="The NLRP3 inflammasome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853884">
<property type="pathway name" value="Transcriptional Regulation by VENTX"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9020702">
<property type="pathway name" value="Interleukin-1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933542">
<property type="pathway name" value="TRAF6 mediated NF-kB activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9660826">
<property type="pathway name" value="Purinergic signaling in leishmaniasis infection"/>
</dbReference>
<dbReference type="SABIO-RK" id="Q04206"/>
<dbReference type="SignaLink" id="Q04206"/>
<dbReference type="SIGNOR" id="Q04206"/>
<dbReference type="BioGRID-ORCS" id="5970">
<property type="hits" value="117 hits in 870 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="RELA">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q04206"/>
<dbReference type="GeneWiki" id="RELA"/>
<dbReference type="GenomeRNAi" id="5970"/>
<dbReference type="Pharos" id="Q04206">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q04206"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="RNAct" id="Q04206">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000173039">
<property type="expression patterns" value="Expressed in tibial artery and 238 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q04206">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q04206">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098978">
<property type="term" value="C:glutamatergic synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035525">
<property type="term" value="C:NF-kappaB p50/p65 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005667">
<property type="term" value="C:transcription regulator complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042805">
<property type="term" value="F:actinin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033613">
<property type="term" value="F:activating transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071532">
<property type="term" value="F:ankyrin repeat binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031490">
<property type="term" value="F:chromatin DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001227">
<property type="term" value="F:DNA-binding transcription repressor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042826">
<property type="term" value="F:histone deacetylase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051059">
<property type="term" value="F:NF-kappaB binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042277">
<property type="term" value="F:peptide binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0042301">
<property type="term" value="F:phosphate ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0047485">
<property type="term" value="F:protein N-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070491">
<property type="term" value="F:repressing transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0000979">
<property type="term" value="F:RNA polymerase II core promoter sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001225">
<property type="term" value="F:RNA polymerase II transcription coactivator binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006117">
<property type="term" value="P:acetaldehyde metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007568">
<property type="term" value="P:aging"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009887">
<property type="term" value="P:animal organ morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006968">
<property type="term" value="P:cellular defense response"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904385">
<property type="term" value="P:cellular response to angiotensin"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035729">
<property type="term" value="P:cellular response to hepatocyte growth factor stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070301">
<property type="term" value="P:cellular response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071347">
<property type="term" value="P:cellular response to interleukin-1"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071354">
<property type="term" value="P:cellular response to interleukin-6"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071222">
<property type="term" value="P:cellular response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071223">
<property type="term" value="P:cellular response to lipoteichoic acid"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071316">
<property type="term" value="P:cellular response to nicotine"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071224">
<property type="term" value="P:cellular response to peptidoglycan"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071356">
<property type="term" value="P:cellular response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035924">
<property type="term" value="P:cellular response to vascular endothelial growth factor stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006325">
<property type="term" value="P:chromatin organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038095">
<property type="term" value="P:Fc-epsilon receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0001942">
<property type="term" value="P:hair follicle development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007249">
<property type="term" value="P:I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070498">
<property type="term" value="P:interleukin-1-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001889">
<property type="term" value="P:liver development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031293">
<property type="term" value="P:membrane protein intracellular domain proteolysis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001237">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046627">
<property type="term" value="P:negative regulation of insulin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1901223">
<property type="term" value="P:negative regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902894">
<property type="term" value="P:negative regulation of pri-miRNA transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042177">
<property type="term" value="P:negative regulation of protein catabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033234">
<property type="term" value="P:negative regulation of protein sumoylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038061">
<property type="term" value="P:NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070431">
<property type="term" value="P:nucleotide-binding oligomerization domain containing 2 signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:1902004">
<property type="term" value="P:positive regulation of amyloid-beta formation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032332">
<property type="term" value="P:positive regulation of chondrocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032735">
<property type="term" value="P:positive regulation of interleukin-12 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032757">
<property type="term" value="P:positive regulation of interleukin-8 production"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904996">
<property type="term" value="P:positive regulation of leukocyte adhesion to vascular endothelial cell"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000630">
<property type="term" value="P:positive regulation of miRNA metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:1901224">
<property type="term" value="P:positive regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:1902895">
<property type="term" value="P:positive regulation of pri-miRNA transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0014040">
<property type="term" value="P:positive regulation of Schwann cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050862">
<property type="term" value="P:positive regulation of T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901522">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032481">
<property type="term" value="P:positive regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0099527">
<property type="term" value="P:postsynapse to nucleus signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043620">
<property type="term" value="P:regulation of DNA-templated transcription in response to stress"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050727">
<property type="term" value="P:regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901222">
<property type="term" value="P:regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0043200">
<property type="term" value="P:response to amino acid"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051591">
<property type="term" value="P:response to cAMP"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033590">
<property type="term" value="P:response to cobalamin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034097">
<property type="term" value="P:response to cytokine"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032868">
<property type="term" value="P:response to insulin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070555">
<property type="term" value="P:response to interleukin-1"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043278">
<property type="term" value="P:response to morphine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032495">
<property type="term" value="P:response to muramyl dipeptide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035994">
<property type="term" value="P:response to muscle stretch"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010033">
<property type="term" value="P:response to organic substance"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032570">
<property type="term" value="P:response to progesterone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010224">
<property type="term" value="P:response to UV-B"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002223">
<property type="term" value="P:stimulatory C-type lectin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033209">
<property type="term" value="P:tumor necrosis factor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd01177">
<property type="entry name" value="IPT_NFkappaB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="DisProt" id="DP00085"/>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.340">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00207"/>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR014756">
<property type="entry name" value="Ig_E-set"/>
</dbReference>
<dbReference type="InterPro" id="IPR002909">
<property type="entry name" value="IPT_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR033926">
<property type="entry name" value="IPT_NFkappaB"/>
</dbReference>
<dbReference type="InterPro" id="IPR000451">
<property type="entry name" value="NFkB/Dor"/>
</dbReference>
<dbReference type="InterPro" id="IPR008967">
<property type="entry name" value="p53-like_TF_DNA-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR030495">
<property type="entry name" value="RelA"/>
</dbReference>
<dbReference type="InterPro" id="IPR030492">
<property type="entry name" value="RHD_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR032397">
<property type="entry name" value="RHD_dimer"/>
</dbReference>
<dbReference type="InterPro" id="IPR011539">
<property type="entry name" value="RHD_DNA_bind_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR037059">
<property type="entry name" value="RHD_DNA_bind_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24169">
<property type="entry name" value="PTHR24169"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24169:SF1">
<property type="entry name" value="PTHR24169:SF1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16179">
<property type="entry name" value="RHD_dimer"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00554">
<property type="entry name" value="RHD_DNA_bind"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00057">
<property type="entry name" value="NFKBTNSCPFCT"/>
</dbReference>
<dbReference type="SMART" id="SM00429">
<property type="entry name" value="IPT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49417">
<property type="entry name" value="SSF49417"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF81296">
<property type="entry name" value="SSF81296"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS01204">
<property type="entry name" value="REL_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50254">
<property type="entry name" value="REL_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0702">S-nitrosylation</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Transcription factor p65" id="PRO_0000205169">
<location>
<begin position="1"/>
<end position="551"/>
</location>
</feature>
<feature type="domain" description="RHD" evidence="9">
<location>
<begin position="19"/>
<end position="306"/>
</location>
</feature>
<feature type="region of interest" description="Transcriptional activation domain 3" evidence="7">
<location>
<begin position="342"/>
<end position="389"/>
</location>
</feature>
<feature type="region of interest" description="Transcriptional activation domain 1" evidence="32">
<location>
<begin position="415"/>
<end position="476"/>
</location>
</feature>
<feature type="region of interest" description="Transcriptional activation domain 2" evidence="7">
<location>
<begin position="520"/>
<end position="551"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="8">
<location>
<begin position="301"/>
<end position="304"/>
</location>
</feature>
<feature type="short sequence motif" description="9aaTAD" evidence="8">
<location>
<begin position="536"/>
<end position="544"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="5">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Cysteine persulfide; alternate" evidence="6">
<location>
<position position="38"/>
</location>
</feature>
<feature type="modified residue" description="S-nitrosocysteine; alternate" evidence="7">
<location>
<position position="38"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by PCAF and EP300; alternate" evidence="14">
<location>
<position position="122"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by PCAF and EP300; alternate" evidence="14">
<location>
<position position="123"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="15">
<location>
<position position="218"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="15">
<location>
<position position="221"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="18">
<location>
<position position="254"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by RPS6KA4 and RPS6KA5" evidence="16">
<location>
<position position="276"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="55">
<location>
<position position="281"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="4 15 29 31 38">
<location>
<position position="310"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine; by SETD6; alternate" evidence="7">
<location>
<position position="310"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKC/PRKCZ" evidence="7">
<location>
<position position="311"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="20">
<location>
<position position="435"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by IKKB and IKKE" evidence="28 30">
<location>
<position position="468"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CHEK1" evidence="25">
<location>
<position position="505"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK2" evidence="12">
<location>
<position position="529"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by IKKB" evidence="10 35">
<location>
<position position="536"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO3)" evidence="42">
<location>
<position position="37"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO3); alternate">
<location>
<position position="122"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO3); alternate">
<location>
<position position="123"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_005587" evidence="53">
<location>
<begin position="13"/>
<end position="25"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_031245" evidence="51">
<location>
<begin position="143"/>
<end position="145"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_012031" evidence="52">
<location>
<begin position="222"/>
<end position="231"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_005588" evidence="53">
<location>
<position position="506"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient diagnosed with autoimmune lymphoproliferative syndrome; unknown pathological significance." id="VAR_081858" evidence="48">
<location>
<begin position="246"/>
<end position="549"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with PIN1." evidence="18">
<original>T</original>
<variation>A</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation." evidence="16">
<original>S</original>
<variation>C</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA80524." ref="2" evidence="54">
<original>E</original>
<variation>R</variation>
<location>
<position position="49"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA36408." ref="1" evidence="54">
<original>S</original>
<variation>P</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA80524." ref="2" evidence="54">
<original>QISQASALA</original>
<variation>RSARPRLG</variation>
<location>
<begin position="372"/>
<end position="380"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="21"/>
<end position="25"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="30"/>
<end position="32"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="39"/>
<end position="41"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="53"/>
<end position="55"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="60"/>
<end position="63"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="68"/>
<end position="80"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="87"/>
<end position="92"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="97"/>
<end position="104"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="109"/>
<end position="112"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="117"/>
<end position="119"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="123"/>
<end position="125"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="126"/>
<end position="129"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="130"/>
<end position="137"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="145"/>
<end position="148"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="156"/>
<end position="166"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="168"/>
<end position="173"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="183"/>
<end position="188"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="196"/>
<end position="200"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="202"/>
<end position="205"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="211"/>
<end position="217"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="225"/>
<end position="230"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="233"/>
<end position="238"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="241"/>
<end position="243"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="246"/>
<end position="248"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="249"/>
<end position="253"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="258"/>
<end position="260"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="266"/>
<end position="273"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="275"/>
<end position="277"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="284"/>
<end position="289"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="294"/>
<end position="302"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="306"/>
<end position="312"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="527"/>
<end position="534"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="535"/>
<end position="540"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="542"/>
<end position="550"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1NFI"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2O61"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5U4K"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250"/>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q04207"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255"/>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00265"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10521409"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10928981"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10938077"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11931769"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12419806"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12456660"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12628924"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12748188"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14690596"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1493333"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15073167"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15226358"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15355351"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15516339"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15629770"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15775976"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15790681"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15799966"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16046471"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16135789"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16407239"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17000776"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1732726"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17467953"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17620405"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17785205"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18212740"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19058135"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19103749"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20547752"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20855622"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21697472"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22649547"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24553141"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26041281"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27736973"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28600438"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29044191"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29305315"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29813070"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31432514"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1732726"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7907305"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000305"/>
<evidence key="55" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="15516339"/>
</source>
</evidence>
<sequence length="551" mass="60219" checksum="8147A6AF9F2445C6" modified="2005-04-26" version="2">MDELFPLIFPAEPAQASGPYVEIIEQPKQRGMRFRYKCEGRSAGSIPGERSTDTTKTHPTIKINGYTGPGTVRISLVTKDPPHRPHPHELVGKDCRDGFYEAELCPDRCIHSFQNLGIQCVKKRDLEQAISQRIQTNNNPFQVPIEEQRGDYDLNAVRLCFQVTVRDPSGRPLRLPPVLSHPIFDNRAPNTAELKICRVNRNSGSCLGGDEIFLLCDKVQKEDIEVYFTGPGWEARGSFSQADVHRQVAIVFRTPPYADPSLQAPVRVSMQLRRPSDRELSEPMEFQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLSQISS</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>